Skip to content

Clinical trials

Overweight trials in Argentina

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Overweight Country / region: Argentina Clear all

48 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20141
20183
20191
20213
20221
20235
20243
202516
202614

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting18
Completed16
Recruiting11
Not yet recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company25
Novo Nordisk A/S8
Amgen3
AstraZeneca3
Hoffmann-La Roche2
Kailera2
Carmot Therapeutics, Inc.1
Mauro Fisberg1
Novartis Pharmaceuticals1
PINER Pastor Manfredi Winery1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Overweight48
Obesity46
Diabetes Mellitus, Type 218
Nutrition Disorders6
Diabetes Mellitus4
Hypertension3
Prediabetic State3
Body Weight2
Diabetes Mellitus, Type 12
Atherosclerosis1

Trials

Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.